| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011089951A1 Prevention/treatment agent for diabetic retinopathy and foodstuff aiming to prevent/treat diabetic retinopathy, ameliorating agent for various symptoms of diabetic retinopathy and foodstuff aiming to ameliorate various symptoms of diabetic retinopathy, and method for determining dosing period of prevention/ameliorating agent for diabetic retinopathy |
| 07/28/2011 | WO2011088745A1 Ophthalmic external antibacterial medicine |
| 07/28/2011 | US20110184358 Pulsatile peri-corneal drug delivery device |
| 07/28/2011 | US20110184220 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 07/28/2011 | US20110184062 Compositions and methods for dry eye syndrome |
| 07/28/2011 | US20110184055 Therapeutic agents for treatment of ocular hypertension |
| 07/28/2011 | US20110184043 Inhibition of angiogenesis |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |
| 07/28/2011 | US20110184017 Stable aqueous solution composition containing sulfonamide compound |
| 07/28/2011 | US20110184015 Novel derivatives of pyrroloindole which are inhibitors of hsp90, compositions containing same, and use thereof |
| 07/28/2011 | US20110184011 Compounds |
| 07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/28/2011 | US20110183965 6-aminoisoquinoline compounds |
| 07/28/2011 | US20110183947 Alpha-keto heterocycles as faah inhibitors |
| 07/28/2011 | US20110183946 Complexes Comprising alpha2-Adrenergic Receptor Agonists and Methods of Providing Neuroprotection or Treating or Inhibiting Progression of Glaucoma |
| 07/28/2011 | US20110183911 Method for improving neurotransmission failure using a novel agent |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110182992 Peptides and peptide mimetics to treat pathologies associated with eye disease |
| 07/28/2011 | US20110182989 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |
| 07/28/2011 | US20110182968 Interpenetrating polymer network hydrogel corneal prosthesis |
| 07/28/2011 | US20110182966 Intracameral sustained release therapeutic agent implants |
| 07/28/2011 | US20110182910 Method of treating t cell mediated disorders |
| 07/28/2011 | US20110182908 Diagnostics and Therapeutics for Macular Degeneration-Related Disorders |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182877 Sustained delivery of compstatin analogs from gels |
| 07/28/2011 | US20110182828 C20-c21 substituted glucocorticoid receptor agonists |
| 07/28/2011 | US20110182819 Methods and Compounds for Promoting Vessel Regression |
| 07/28/2011 | CA2787782A1 Therapeutic substituted chlorocyclopentanols |
| 07/28/2011 | CA2787573A1 Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | CA2786730A1 5-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye |
| 07/27/2011 | EP2347771A1 Peptide-based compounds for targeted imaging |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2346827A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| 07/27/2011 | EP2346520A1 Curcuminoids and its metabolites for the application in ocular diseases |
| 07/27/2011 | EP2346513A1 Compositions comprising polymers having amino sugar units and methods of making and using same |
| 07/27/2011 | EP1598349B1 Novel 2-pyridinecarboxamide derivatives |
| 07/27/2011 | EP1443928B1 Treatment of neurodegenerative diseases and cancer of the brain |
| 07/27/2011 | EP1389616B1 3,4-Dihalobenzylpiperidine derivatives and their medical use |
| 07/27/2011 | CN1903188B Application of teprenone for preparing medicine for treating and/or preventing glaucoma |
| 07/27/2011 | CN1747744B Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 07/27/2011 | CN102137863A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137862A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137654A Methods and ophtalmic devices used in the treatment of ocular allergies |
| 07/27/2011 | CN102134215A Derivative of Fexofenadine and composite and application thereof |
| 07/27/2011 | CN102133407A Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 07/27/2011 | CN102133209A Eye protection patches and preparation process thereof |
| 07/27/2011 | CN102133018A Health care drug pillow |
| 07/27/2011 | CN101843857B Chinese medicament for treating diabetic eyeground pathological changes |
| 07/27/2011 | CN101843837B Chinese medicament for treating diabetic oculopathy |
| 07/27/2011 | CN101716144B Lutein-hydrogenated phospholipid liposome precursor and preparation method thereof |
| 07/27/2011 | CN101703559B Medicinal composition with function of relieving visual fatigue and preparation method thereof |
| 07/27/2011 | CN101700379B Traditional Chinese medicine preparation for treating central serous chorioretinopathy |
| 07/27/2011 | CN101658588B Traditional Chinese medicine composition and preparation method thereof |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/27/2011 | CN101537010B Eyedrop preparation and preparation method thereof |
| 07/27/2011 | CN101342250B Bolus for clearing away heat of the upper part of the body |
| 07/27/2011 | CN101336934B Bear bile buccal tablet and preparation process thereof |
| 07/27/2011 | CN101204579B Application of regrouped human minute plasminogen on process for preparing the medicine curing eye disorders |
| 07/27/2011 | CN101057695B Method for preparing nutrition supplementing beverage for eye |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985411 Activatable recombinant neurotoxins |
| 07/26/2011 | CA2484981C 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 07/26/2011 | CA2464333C Heteroindanes: a new class of potent cannabimimetic ligands |
| 07/26/2011 | CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization |
| 07/26/2011 | CA2268331C Treatment of inner ear hair cells |
| 07/21/2011 | WO2011087790A1 Triple combination for lowering intraocular pres sure |
| 07/21/2011 | WO2011087066A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | WO2011086163A1 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors |
| 07/21/2011 | US20110178165 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof |
| 07/21/2011 | US20110178158 Set of Antiangiogenic Molecules and Use Thereof |
| 07/21/2011 | US20110178147 Compositions and methods for controlling pupil dilation |
| 07/21/2011 | US20110178145 Alpha-2 adrenergic agonist having long duration ofintraocular pressure-lowering effect |
| 07/21/2011 | US20110178144 Therapeutic compounds |
| 07/21/2011 | US20110178143 Therapeutic compounds |
| 07/21/2011 | US20110178141 Thiazoliums and Their Use for Treating Protein Aging Associated Diseases |
| 07/21/2011 | US20110178130 MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 07/21/2011 | US20110178121 Methods for Treating Pain |
| 07/21/2011 | US20110178112 PPAR Modulators |
| 07/21/2011 | US20110178099 Pharmaceutical combination |
| 07/21/2011 | US20110178082 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178081 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177171 Oxygenated Ophthalmic Compositions and Methods of Use |
| 07/21/2011 | US20110177169 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 07/21/2011 | US20110177074 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 07/21/2011 | US20110177049 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/21/2011 | US20110177047 Methods and compositions for preventing or treating ophthalmic conditions |
| 07/21/2011 | US20110173928 Process to improve stability of a pharmaceutical composition |
| 07/21/2011 | CA2785970A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/20/2011 | EP2345637A2 3, 10, and 12a substituted tetracycline compounds |
| 07/20/2011 | EP2344493A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/20/2011 | EP2344492A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/20/2011 | EP2344451A2 Sulfur-linked compounds for treating opthalmic diseases and disorders |
| 07/20/2011 | EP2344155A2 Composition and method for treating dry eye syndrome |
| 07/20/2011 | EP2344151A2 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 07/20/2011 | EP2344144A1 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus |